Cardiff Park Advisors’s Amgen AMGN Stock Holding History

Cardiff Park Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Hold	646	–	–	0.02%	247
2026 Q1	$227K	Sell	646 -120	-16%	-$42.8K	0.02%	262
2025 Q4	$251K	Hold	766	–	–	0.02%	238
2025 Q3	$216K	Hold	766	–	–	0.02%	280
2025 Q2	$214K	Hold	766	–	–	0.02%	254
2025 Q1	$239K	Sell	766 -35	-4%	-$10.3K	0.02%	236
2024 Q4	$209K	Hold	801	–	–	0.02%	247
2024 Q3	$258K	Hold	801	–	–	0.02%	222
2024 Q2	$250K	Hold	801	–	–	0.02%	218
2024 Q1	$228K	Hold	801	–	–	0.02%	238
2023 Q4	$231K	Hold	801	–	–	0.03%	211
2023 Q3	$215K	Buy	+801	New	+$200K	0.03%	206

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Cardiff Park Advisors's AMGN Position: Q2 2026 in Review

Cardiff Park Advisors held its Amgen (AMGN) position steady in Q2 2026 at 646 shares worth $234K. The position accounts for 0.02% of the portfolio, ranked #247.

Cardiff Park Advisors first reported a position in AMGN in Q3 2023 and has held it in 12 quarters since. The position peaked at $258K in Q3 2024. 3,160 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Cardiff Park Advisors held 646 shares of Amgen worth $234K as of Q2 2026.
Cardiff Park Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up 0.02% of Cardiff Park Advisors's portfolio in Q2 2026, its #247 holding.
Cardiff Park Advisors first reported a position in Amgen in Q3 2023 and has held it in 12 quarters since.
Cardiff Park Advisors's Amgen position peaked at $258K in Q3 2024.
3,160 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cardiff Park Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.